A single human error in India prompts GE Healthcare to issue a warning on 30 years worth of its MRI scanners.
ViewRay registers for an initial public offering worth up to $69 million for its MRIdian cancer detection and radiation treatment device.
ViewRay last week said it plans to raise up to $69 million in an initial public offering for its MRIdian system, which it bills as "the 1st and only MRI-guided radiation therapy system that images and treats cancer patients simultaneously."
Smith & Nephew joins a $3.8 million Series B round for Michelson Diagnostics and its VivoSight OCT-based skin cancer detection device.
Sorin Group wins Japanese regulatory approval for a next-generation pacemaker implant that's safe for MRI scans.
Sorin Group (BIT:SRN) said it gained regulatory approval in Japan for a next-generation pacemaker implant safe for MRI scans.
Koning Corp. says the FDA granted pre-market approval for its 3D computed tomography device for breast imaging.
New York's Koning Corp. said it nailed down pre-market approval from the FDA for a new 3D breast imaging system and related equipment.
The closure of a Cleveland plant that makes CT scanners pushed Royal Philips' overall profits down and slashed its Philips Healthcare division's bottom line by nearly 28%.
Med-El wins pre-market approval from the FDA for its Synchrony MRI-safe cochlear implant.
Med-El USA said it plans to start selling its Synchrony MRI-safe cochlear implant in the spring of 2015, following the FDA's decision to sign off on the novel device.